GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2452.4 and 2518.9
| Intraday Target 1 | 2398.43 |
| Intraday Target 2 | 2439.87 |
| Intraday Target 3 | 2464.9333333333 |
| Intraday Target 4 | 2506.37 |
| Intraday Target 5 | 2531.43 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Thu 07 May 2026 | 2481.30 (2.39%) | 2423.50 | 2423.50 - 2490.00 | 1.3052 times | Wed 06 May 2026 | 2423.30 (2.52%) | 2380.00 | 2365.00 - 2450.00 | 0.7049 times | Tue 05 May 2026 | 2363.70 (0.59%) | 2335.00 | 2335.00 - 2399.00 | 1.0429 times | Mon 04 May 2026 | 2349.90 (0.58%) | 2342.00 | 2322.50 - 2387.40 | 1.1479 times | Thu 30 April 2026 | 2336.40 (-1.28%) | 2367.20 | 2319.40 - 2370.80 | 1.1438 times | Wed 29 April 2026 | 2366.60 (-1.81%) | 2415.00 | 2359.50 - 2428.50 | 1.6227 times | Tue 28 April 2026 | 2410.20 (-1.19%) | 2450.00 | 2404.20 - 2466.30 | 0.5342 times | Mon 27 April 2026 | 2439.20 (-1.33%) | 2472.00 | 2427.00 - 2495.00 | 1.2257 times | Fri 24 April 2026 | 2472.00 (-0.91%) | 2496.40 | 2459.80 - 2509.60 | 0.5685 times | Thu 23 April 2026 | 2494.60 (1.18%) | 2480.00 | 2456.00 - 2529.90 | 0.7042 times | Wed 22 April 2026 | 2465.60 (1.57%) | 2420.20 | 2397.10 - 2496.00 | 0.5897 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2401.9 and 2569.4
| Weekly Target 1 | 2263.77 |
| Weekly Target 2 | 2372.53 |
| Weekly Target 3 | 2431.2666666667 |
| Weekly Target 4 | 2540.03 |
| Weekly Target 5 | 2598.77 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Thu 07 May 2026 | 2481.30 (6.2%) | 2342.00 | 2322.50 - 2490.00 | 1.5097 times | Thu 30 April 2026 | 2336.40 (-5.49%) | 2472.00 | 2319.40 - 2495.00 | 1.6266 times | Fri 24 April 2026 | 2472.00 (0.74%) | 2465.00 | 2397.10 - 2529.90 | 0.8691 times | Fri 17 April 2026 | 2453.90 (2.5%) | 2370.10 | 2341.20 - 2468.80 | 0.7296 times | Fri 10 April 2026 | 2394.00 (3.57%) | 2307.00 | 2267.80 - 2431.80 | 0.8278 times | Thu 02 April 2026 | 2311.50 (2.3%) | 2259.50 | 2217.60 - 2401.90 | 1.1173 times | Fri 27 March 2026 | 2259.50 (-5.25%) | 2353.40 | 2255.10 - 2364.90 | 0.9088 times | Fri 20 March 2026 | 2384.80 (-1.63%) | 2413.00 | 2362.50 - 2472.00 | 0.6623 times | Fri 13 March 2026 | 2424.30 (-3.69%) | 2500.00 | 2397.70 - 2554.00 | 0.8891 times | Fri 06 March 2026 | 2517.30 (-2.11%) | 2520.00 | 2450.10 - 2581.60 | 0.8597 times | Fri 27 February 2026 | 2571.60 (-0.97%) | 2616.80 | 2566.00 - 2668.80 | 0.8583 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2401.9 and 2569.4
| Monthly Target 1 | 2263.77 |
| Monthly Target 2 | 2372.53 |
| Monthly Target 3 | 2431.2666666667 |
| Monthly Target 4 | 2540.03 |
| Monthly Target 5 | 2598.77 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Thu 07 May 2026 | 2481.30 (6.2%) | 2342.00 | 2322.50 - 2490.00 | 0.2684 times | Thu 30 April 2026 | 2336.40 (2.34%) | 2305.00 | 2261.90 - 2529.90 | 0.8361 times | Mon 30 March 2026 | 2283.00 (-11.22%) | 2520.00 | 2217.60 - 2581.60 | 0.6737 times | Fri 27 February 2026 | 2571.60 (7.08%) | 2421.40 | 2342.10 - 2719.80 | 0.983 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.8781 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 1.4351 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 1.1969 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.7772 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 1.2381 times | Fri 29 August 2025 | 2785.00 (-11.94%) | 3162.90 | 2560.00 - 3184.30 | 1.7134 times | Thu 31 July 2025 | 3162.60 (-6.66%) | 3388.70 | 3072.50 - 3450.00 | 1.0461 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2349.45 and 2851.65
| Yearly Target 1 | 1970.7 |
| Yearly Target 2 | 2226 |
| Yearly Target 3 | 2472.9 |
| Yearly Target 4 | 2728.2 |
| Yearly Target 5 | 2975.1 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Thu 07 May 2026 | 2481.30 (0.31%) | 2476.00 | 2217.60 - 2719.80 | 0.3151 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.6278 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.2341 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.2419 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.7214 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9622 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0738 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4593 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2336 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1306 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1309 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in uptrend. And this trend seems to be continuing further.
Price is above an important level of 2410.27 on charts, and as long as price remains above this level, the uptrend of stock might continue.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be moving in a flat line. No recent bulk deals happened to affect the stock trend.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears strongly Bullish. This stock started moving upwards as soon as it opened. Generally this happens when there is a positive sentiment following the stock, making it attractive. There's a good chance that this upwards movement will continue tomorrow as well.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO is bullish. The stock is trading above weekly resistance and downside can only be expected once it trades below 2415.7
Munafa value: 95 as on Thu 07 May 2026
This Munafa value indicates that the stock is moving upwards and might continue to move up.
SMA20 is at 2414 and price is deviating by 46 points
Upper Bollinger band is at 2505 and lower is at 2322, while middle bands are at 2368 and 2459
Price is rising
Price is above 20day SMA
Price is in upper range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for GlaxosmithklinePharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
GlaxosmithklinePharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for GlaxosmithklinePharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of GlaxosmithklinePharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2406.13 and GlaxosmithklinePharmaceuticals GLAXO stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2390.92 |
| 12 day DMA | 2419.18 |
| 20 day DMA | 2413.06 |
| 35 day DMA | 2385.44 |
| 50 day DMA | 2435.67 |
| 100 day DMA | 2455.05 |
| 150 day DMA | 2510.63 |
| 200 day DMA | 2601.01 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2419.76 | 2389 | 2371.85 |
| 12 day EMA | 2410.29 | 2397.38 | 2392.67 |
| 20 day EMA | 2409.59 | 2402.04 | 2399.8 |
| 35 day EMA | 2432.6 | 2429.73 | 2430.11 |
| 50 day EMA | 2445.99 | 2444.55 | 2445.42 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2390.92 | 2367.98 | 2365.36 |
| 12 day SMA | 2419.18 | 2414.9 | 2417.45 |
| 20 day SMA | 2413.06 | 2405.67 | 2401.83 |
| 35 day SMA | 2385.44 | 2386.1 | 2387.89 |
| 50 day SMA | 2435.67 | 2437.72 | 2441.33 |
| 100 day SMA | 2455.05 | 2455.68 | 2456.9 |
| 150 day SMA | 2510.63 | 2512.39 | 2514.65 |
| 200 day SMA | 2601.01 | 2604.54 | 2608.65 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 60.27 and PE is: 41.17
Last quarter profit: (December 2025 quarter) 295.62 crores (22.82%)
Debt: 35.71 in crores
Market capitalization: 38277.29
EPS is 56.39 and PE is: 44
Last quarter profit: (September 2025 quarter) 257.49 crores (2.57%)
Debt: 35.71 in crores
Market capitalization: 43709.18
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance


